Oncology: 2015 ASH Review What is Refractory AML Presented by Eli Estey, MD
Live

New Course
1.Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs. 2.Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awareness of potential problems identified through M&M and/or continuous quality improvem

Release Date: 1/23/2017   |   End Date: 4/18/2018

2015 ASH Review –What is Refractory AML

Presented by Eli Estey, MD

Mayo Clinic Cancer Center, Arizona

  • Release date: January 23, 2017
  • Expiration date: April 18, 2018
  • Estimated time to complete activity: NO CME


For all questions/concerns, contact the HealthONE Office of Continuing Medical Education at 303.584.6006 or stacy.weiss@healthonecares.com 

Policy on Privacy and Confidentiality


DISCLOSURES

HealthONE CME assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by HealthONE CME for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HealthONE CME is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity. The faculty members have reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity.

  • Nancy L. Bartlett, MD has no relevant conflicts of interest to report.

The following members of the Denver CME Committee hereby state that they or their spouse/life partner do not have any financial relationships or relationships in any amount during the past 12 months to products, devices, or any commercial interests related to the content of this CE activity:

  • Stacy Weiss, MA
  • Lindy Garvin
  • Gary Winfield, MD
  • Judy Hariton
  • Laura Fennell-Nelson
  • Adam Pritchard

The following members of the Planning Committee hereby state that they or their spouse/life partner do not have any financial relationships or relationships in any amount during the past 12 months to products, devices, or any commercial interests related to the content of this CE activity:

  • Jill Domsch, MHA
  • Stacy Weiss, MA

The following HealthONE clinical content reviewers hereby state that they or their spouse/life partner do not have any financial relationships or relationships in any amount during the past 12 months to products, devices, or any commercial interests related to the content of this CE activity:

  • Gary Winfield, MD

LEARNING OBJECTIVES 

Following the presentation, each participant should be able to:

  1. Improve patient management through the introduction of new or updated knowledge, techniques, equipment, or drugs.
  2. Identify appropriate procedures and treatments and attempt to modify behaviors, change practice patterns or raise awareness of potential problems identified through M&M and/or continuous quality improvements.
  3. Improve the quality and safety of diagnosis and treatment and provide frequent updates on new drugs, new treatment options or basic science research information.
  4. Review new advances in the most current therapeutic approach for various disease states

LEVEL OF EVIDENCE 

HealthONE CME has designated 3 Levels of Evidence for CME presentations:

  1. Evidence mainly from randomized or non-randomized, well designed controlled trials; well-designed cohort or case-controlled analytic studies.
  2. Evidence from multiple studies with or without the intervention being targeted, meta-analysis, opinions of respected authorities or expert panels, or information based on case reports.
  3. Uncontrolled experiments, descriptive studies, presenter’s clinical experience/opinion or research in progress.
  • The majority of this presentation will be based on Level 1, 2 and 3 Evidence. 

 


 

ACCREDITATION & CREDIT DESIGNATION STATEMENTS 

HealthONE CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

HealthONE CME designates this enduring activity for a maximum of 1 AMA PRA Category I Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

DISCLAIMER 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 
 

UNLABELED/UNAPPROVED USES NOTICE 

In accordance with the ACCME Essential Areas and Policies, as well as, the Standards for Commercial Support, the audience is advised that this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices.  Specific medicines discussed in this program may not yet be specifically approved and/or may not be specified to be used as indicated by the speakers. Before prescribing any medication, review the complete prescribing information, including indications, contraindications, warnings, precautions and adverse effects.

POST-TEST and PROGRAM EVALUATION 

Please take a few minutes to complete the evaluation form. This information is used not only to evaluate the present symposium, but also to plan for future programs. Successful completion of the post-test and evaluation generates your CME certificate.